HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US RSS
 
Subscriber Sign In
 
Today@FDA
FDA Calendar
 
Archived Daily Updates
 
FDA Whistleblower
 
What do you think?
Search our 63,616-story database
Search
Renew subscription










E-mail This to a Friend | Print Format  
     
 
BioElectronics 510(k) for ActPatch for Musculoskeletal Pain
07/12/2018
 

BioElectronics has submitted a 510(k) for ActiPatch and its over-the-counter adjunctive use in treating musculoskeletal pain. The device is currently cleared for adjunctive treatment of pain from knee osteoarthritis and plantar fasciitis. The expanded market clearance would allow for additional use for the back, neck, hip, shoulder, carpal tunnel and many other musculoskeletal complaints. The pulsed shortwave therapy device comprises low voltage digital/analog electronics that control all timing functions to produce the therapeutic radiofrequency field, the company says. An antenna is placed directly above the therapeutic site.


Post an instant comment on this report here

 
Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com